Tuesday, Hall 8, 13:30-14:10

S1P Receptor Modulators: From Clinical Trials To Clinical Practice

This is a promotional symposium organised and funded by Pfizer UK and is intended for GB Healthcare Professionals, Pfizer products will be discussed.

Professor Charlie Lees
Professor of Gastroenterology
University of Edinburgh
Consultant Gastroenterologist
Western General Hospital, Edinburgh IBD Unit

Professor Charlie Lees has acted as a speaker and/or consultant to AbbVie, Janssen, Takeda, Pfizer, Galapagos, GSK, Gilead, Vifor Pharma, Ferring, Dr Falk, BMS, Boehringer Ingelheim, Novartis, Sandoz, Celltrion, Celgene, Amgen, Samsung Bioepis, Fresenius Kabi, Tillotts, Trellus Health, and Iterative Scopes.

Professor Peter Irving
Consultant Gastroenterologist
Guy’s and St Thomas’ NHS Foundation Trust
Professor of Gastroenterology
King’s College London

Lecture fees: AbbVie, BMS, Celgene, Celltrion, Falk Pharma, Ferring, Galapagos, Gilead, MSD, Janssen, Pfizer, Takeda, Tillotts, Sapphire Medical, Sandoz, Shire and Warner Chilcott.

Financial support for research: Celltrion, MSD, Pfizer, Takeda and Galapagos.

Advisory fees: AbbVie, Arena, Boehringer Ingelheim, BMS, Celgene, Celltrion, Genentech, Gilead, Hospira, Janssen, Lilly, MSD, Pfizer, Pharmacosmos, Prometheus, Roche, Sandoz, Samsung Bioepis, Takeda, Topivert, VH2, Vifor Pharma and Warner Chilcott.

PP-UNP-GBR-9221 May 2024